2016 Fiscal Year Final Research Report
Study of muscle AMPK-dependent factors that improve metabolic abnormalities in strepotozocin-induced diabetes
Project/Area Number |
15K15352
|
Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
Allocation Type | Multi-year Fund |
Research Field |
Metabolomics
|
Research Institution | National Institute for Physiological Sciences |
Principal Investigator |
|
Co-Investigator(Renkei-kenkyūsha) |
OKAMOTO Shiki 琉球大学, 医学研究科, 特命講師 (40342919)
YOKOTA Shigefumi 生理学研究所, 生体機能調節研究領域, NIPSリサーチフェロー (50725281)
|
Research Collaborator |
SAITO Kumiko 生理学研究所, 技術課, 係長
|
Project Period (FY) |
2015-04-01 – 2017-03-31
|
Keywords | AMPK / streptozotocin / myokine / leptin |
Outline of Final Research Achievements |
AMP kinase (AMPK) is a metabolic sensor that plays an important role in obesity and diabetes. I found that muscle-specific dominant negative AMPK-epxressing transgenic mice (DN-AMPK Tg mice) suppress metabolic abnormalities in streptozotocin-inducd type 1 diabetes. The study revealed that IL-6, irisin, and leptin are involved in the effects of muscle DN-AMPK on streptozotocin-inducd diabetes.
|
Free Research Field |
代謝学
|